Directors' Dealings
12 August 2019
James Cropper plc
(the "Company")
Directors' Dealings
The Company was notified on 9 August 2019 that on the same day, Lyndsey Scott, a Director of the Company, purchased 500 ordinary shares of 25p each in the Company ("Shares") at a price of 1,150.0p per Share.
As a result of the above, Lyndsey Scott's interest in the Company has increased by 500 Shares.
Enquiries:
James Cropper PLC (AIM: CRPR) Isabelle Maddock, Group Finance Director Jim Aldridge, Company Secretary Tel: +44 (0) 1539 722002 www.jamescropper.com
| Shore Capital Robert Finlay, Henry Willcocks Richard Johnson Tel: + 44 (0) 207 601 6100
|
The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:
1
| Details of the person discharging managerial responsibilities / person closely associated | |||||
a)
| Names | Lyndsey Scott | ||||
2
| Reason for the notification | |||||
a)
| Position/status
| Non-Executive Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name | James Cropper plc | ||||
b)
| LEI | 213800XM78VTDYGBRM93 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
| Ordinary Shares of 25p each | ||||
b) | Identification code
| GB0002346053 | ||||
c)
| Nature of the transaction
| Buy | ||||
d)
| Price(s) and volume(s) |
| ||||
d)
| Aggregated information - Aggregated volume - Price |
500 5,750.00 | ||||
e)
| Date of the transaction | 9 August 2019 | ||||
f)
| Place of the transaction | London |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.